Sturm Ruger options flow points to M&A arbitrage hedging after Beretta stake bid
Sturm Ruger & Co. (RGR) stock rose 6.73% to $39.58 after Beretta Holding S.A. announced plans to increase its stake to 25% and gain board seats. RGR accelerated the termination of its shareholder rights plan. Unusual options activity, including deep in-the-money puts, suggests M&A arbitrage hedging amid deal uncertainty. Traders are hedging against potential deal collapse or post-announcement fade.
How this was made
The 30-second read
Why it matters
The M&A arbitrage signal suggests a short‑term upside target, but put‑skew indicates market concern over deal completion risk.
Market read
RGR is the primary mover; the news creates a clear arbitrage play for traders.
What to watch
Regulatory scrutiny of foreign ownership in U.S. firearms could delay or block a full takeover.
Background
Sturm Ruger shares rose 6.73% after the bid announcement and poison‑pill removal, while options flow shows deep‑ITM put hedging.
Ticker impact
Beretta Holding announced a bid to raise its stake in Sturm Ruger to 25% and Ruger terminated its poison pill, creating M&A arbitrage opportunity.
RGR could rally 10‑15% on deal completion; downside limited by deep‑ITM put hedges.
Deal size relative to market cap is material, and the stock already jumped 6.7% on the news.
Market effects
The firearms sector may see increased M&A activity as strategic investors seek larger positions.
U.S. defense‑related equities could see modest buying pressure.
European investor interest may rise due to Beretta's involvement.
Counterpoint
If Beretta only seeks influence, the 25% stake may cap upside and the stock could retreat from current levels.
Key entities
- CompanySturm Ruger & Co.
U.S. firearms manufacturer, ticker RGR.
- CompanyBeretta Holding S.A.
Italian firearms group seeking a larger stake in Ruger.
